Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director,...